CD8+ T-cells target the Crimean-Congo haemorrhagic fever virus Gc protein to control the infection in wild-type mice

EBioMedicine. 2023 Nov:97:104839. doi: 10.1016/j.ebiom.2023.104839. Epub 2023 Oct 20.

Abstract

Background: Crimean-Congo haemorrhagic fever (CCHF) is a serious viral hemorrhagic fever caused by the CCHF virus (CCHFV). Spread by the bites of infected ticks or handling of viremic livestock, human disease is characterized by a non-specific febrile illness that can rapidly progress to fatal hemorrhagic disease. No vaccines or antivirals are available. Case fatality rates can vary but can be higher than 30%, although sub-clinical infections are often unrecognized and unreported. Yet, while most humans infected with CCHFV will survive the infection, often with little-to-no symptoms, the host responses that control the infection are unknown.

Methods: Here we investigated the role of cellular immunity in control of CCHFV infection in an immunocompetent mouse model.

Findings: We found that CD8+ T-cells are crucial for efficient control of the acute infection and rapidly acquired CCHFV-specific antiviral effector functions such as production of antiviral cytokines and degranulating in response to CCHFV peptides. We further identified the minimal CD8+ T-cell epitopes in the viral Gc proteins and that infection of mice lacking IFNγ resulted in worsened disease and higher viral loads.

Interpretation: Together our data suggest that CD8+ T-cells are important for control of acute CCHFV infection likely through production of antiviral cytokines.

Funding: This work was supported by the Intramural Research Program of the NIH.

Keywords: Adaptive immunity; CCHFV; Crimean-Congo haemorrhagic fever; Mouse model; T-cells.

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use
  • CD8-Positive T-Lymphocytes
  • Cytokines
  • Hemorrhagic Fever Virus, Crimean-Congo* / physiology
  • Hemorrhagic Fever, Crimean* / drug therapy
  • Humans
  • Mice

Substances

  • Antiviral Agents
  • Cytokines